Recurrent Respiratory Papillomatosis Successfully Treated with Gefitinib: A Case Study

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F15%3A33158396" target="_blank" >RIV/61989592:15110/15:33158396 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.12691/ajmcr-3-11-2" target="_blank" >http://dx.doi.org/10.12691/ajmcr-3-11-2</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.12691/ajmcr-3-11-2" target="_blank" >10.12691/ajmcr-3-11-2</a>

Result language
angličtina
Original language name
Recurrent Respiratory Papillomatosis Successfully Treated with Gefitinib: A Case Study
Original language description
Recurrent respiratory papillomatosis (RRP) is a rare condition caused by infection of the respiratory tract mucosa with human papillomaviruses. The disease is characterized by a growth of mucosal papillomas, mostly in the laryngeal region and rarely in the more distal parts of the airways. The therapy is often difficult, including both mechanical removal of papillomas and pharmacological therapy. Presented in the article is a case of regression of papillomatosis in the larynx, trachea and lung parenchyma after administration of gefitinib, an endothelial growth factor receptor inhibitor.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
<a href="/en/project/NT13569" target="_blank" >NT13569: Identification of prognostic and predictive factors in non-small cell lung cancer patients treated by adjuvant chemotherapy.</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)